Skip to main content
. 2019 May 24;26(5):637–650. doi: 10.1007/s12282-019-00970-7

Fig. 3.

Fig. 3

Tumor shrinkage in Japanese patients. Changes in tumor size for individual patients without (left) and with (right) dose reduction within 180 days of treatment initiation in a PALOMA-2, b Japanese phase 2 study, and c PALOMA-3. FUL fulvestrant, LET letrozole, PAL palbociclib